Report updated Apr 30, 2026
AnticoagEvaluator
For healthcare professionals managing antithrombotic therapy for patients with non-valvular atrial fibrillation.
Overview · Full Intel report in progress
AnticoagEvaluator is an established medical app that is completely free. With a 4.7/5 rating from 71 reviews, it shows polarized user reception.
What is AnticoagEvaluator?
Current Momentum
v5.0 · 17mo ago
ZombieLast updated 524d ago. 5 versions tracked.
Competition
Rivals identification in progress
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Calculates a patient's renal function and risk levels for ischemic stroke, thromboembolism, and bleeding.
Provides ACC/AHA/HRS clinical guidance for stroke prevention strategies.
Generates therapy options based on clinical trial data tailored to specific patient characteristics.
Assists in the accurate use of direct oral anticoagulants by adjusting dosages based on renal function and patient-specific data.
How much does it cost?
Who Built It?
What other apps does American College of Cardiology make?
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
Analysis in progress, available soon
What is the competitive landscape for AnticoagEvaluator?
How's The Medical Market?
Market outlook for this category
Available very soon
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for AnticoagEvaluator
Key Takeaways
While the app offers specialized clinical decision support, recent user feedback indicates potential technical instability regarding therapy detail navigation.
Where Is It Heading?
Trend analysis
Available very soon